Integration of somatic mutations in diagnosis and risk assessment in myelodysplastic syndromes (MDS)

被引：0
|
作者：
Della Porta, M. [1 ,2 ]
机构：
[1] Humanitas Res Hosp, Milan, Italy
[2] Humanitas Univ, Milan, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O6.01
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [31] Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS)
    Du, Yan
    Fryzek, Jon
    Sekeres, Mikkael A.
    Taioli, Emanuela
    LEUKEMIA RESEARCH, 2010, 34 (01) : 1 - 5
  • [32] Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Cazzola, Mario
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 349 - 352
  • [33] CAN SOMATIC MUTATIONS BE USED IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME?
    Alqaidy, Doaa
    Xie, Yi
    Prakash, Sonam
    Wang, Linlin
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 5 - 5
  • [34] The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients
    Stauder, Reinhard
    ANNALS OF HEMATOLOGY, 2012, 91 (09) : 1333 - 1343
  • [35] The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients
    Reinhard Stauder
    Annals of Hematology, 2012, 91 : 1333 - 1343
  • [36] BCOR Mutations in Myelodysplastic Syndromes (MDS): Mutation Characteristics Impact Clinical Outcomes
    Abuhadra, Nour
    Al-Issa, Karam
    Mukherjee, Sudipto
    Hirsch, Cassandra M.
    Gerds, Aaron T.
    Jha, Babal K.
    Adema, Vera
    Awada, Hassan
    Asad, Mohammad Fahad B.
    Goyal, Abhinav
    Advani, Anjali S.
    Nagata, Yasunobu
    Przychodzen, Bartlomiej P.
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Nazha, Aziz
    BLOOD, 2017, 130
  • [37] Prevalence of hemochromatosis gene (HFE) mutations in Greek patients with myelodysplastic syndromes (MDS).
    Speletas, M
    Vlachaki, E
    Papaioannou, G
    Tzoanopoulos, D
    Vasilikioti, S
    Mandala, E
    Ritis, K
    Kartalis, G
    Korantzis, I
    BLOOD, 2001, 98 (11) : 276B - 276B
  • [38] Analysis of flt3 gene mutations and expression in myelodysplastic syndromes (MDS).
    Papageorgiou, S
    Pappa, V
    Economopoulos, T
    Papageorgiou, E
    Dervenoulas, J
    Mantzios, G
    Kontsioti, F
    Valsami, S
    Raptis, S
    BLOOD, 2001, 98 (11) : 355A - 356A
  • [39] Mutations in splicing factor genes and their diagnostic impact on patients with myelodysplastic syndromes (MDS)
    Aghova, Tatiana
    Lhotska, Halka
    Svobodova, Karla
    Hodanova, Lucie
    Lizcova, Libuse
    Pavlistova, Lenka
    Luksikova, Karolina
    Sotakova, Slavka
    Minarik, Lubomir
    Stopka, Tomas
    Jonasova, Anna
    Zemanova, Zuzana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 605 - 606
  • [40] Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations
    Polprasert, Chantana
    Niparuck, Pimjai
    Rattanathammethee, Thanawat
    Chuncharunee, Suporn
    Kobbuaklee, Sirorat
    Songserm, Kritanan
    Suksusut, Amornchai
    Trithiphen, Sasinipa
    Lanamtieng, Theerin
    Kongkiatkamon, Sunisa
    Chanswangphuwana, Chantiya
    Lawasut, Panisinee
    Bunworasate, Udomsak
    Rojnuckarin, Ponlapat
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : E293 - E299
12345